{"id":"W2464620827","doi":"10.1200/jco.2016.66.9861","title":"Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Pemetrexed; Carboplatin; Tolerability; Gemcitabine; Lung cancer; Oncology; Internal medicine; Cisplatin; Chemotherapy; Paclitaxel; Adverse effect; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007934341,0.0001322089,0.001082549,0.0001201313,0.00001955834,0.000002296959,0.00008168651,0.0002134392,0.0001287781],"category_scores_gemma":[0.0001094945,0.00006993033,0.0003238459,0.0001216178,0.0001174873,0.00005894275,0.000003925778,0.000121506,3.614231e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005265014,"about_ca_system_score_gemma":0.001484462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000623852,"about_ca_topic_score_gemma":0.0006493477,"domain_scores_codex":[0.9979666,0.00006703631,0.001471404,0.0001532082,0.0001679885,0.0001737944],"domain_scores_gemma":[0.9965015,0.001409372,0.001515031,0.0001401145,0.0003334626,0.0001004984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1787879,0.006254357,0.1529047,0.0001331407,0.0005158485,0.00005065888,0.0001972978,0.0001304863,0.009130185,0.000006192299,0.0006035474,0.6512856],"study_design_scores_gemma":[0.5029155,0.1553511,0.2468998,0.001377047,0.0005401635,0.00003791375,0.00009142532,0.001163911,0.02879559,0.00008537974,0.06250433,0.0002379157],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803281,0.0007073705,0.002726915,0.0149018,0.0004102401,0.0007352623,0.00001036878,0.000004320901,0.0001755959],"genre_scores_gemma":[0.9901904,0.003071555,0.005049092,0.0008619676,0.0002802976,0.0000490887,0.00000279956,0.00002098202,0.0004738586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6510478,"threshold_uncertainty_score":0.2851676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06176889032220338,"score_gpt":0.424635470981647,"score_spread":0.3628665806594436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}